Direct medical costs after surgical or nonsurgical treatment for degenerative lumbar spinal disease: A nationwide matched cohort study with a 10-year follow-up

PLoS One. 2021 Dec 1;16(12):e0260460. doi: 10.1371/journal.pone.0260460. eCollection 2021.

Abstract

Objective: The demand for treating degenerative lumbar spinal disease has been increasing, leading to increased utilization of medical resources. Thus, we need to understand how the budget of insurance is currently used. The objective of the present study is to overview the utilization of the National Health Insurance Service (NHIS) by providing the direct insured cost between patients receiving surgery and patients receiving nonsurgical treatment for degenerative lumbar disease.

Methods: The NHIS-National Sample Cohort was utilized to select patients with lumbar disc herniation, spinal stenosis, spondylolisthesis or spondylolysis. A matched cohort study design was used to show direct medical costs of surgery (n = 2,698) and nonsurgical (n = 2,698) cohorts. Non-surgical treatment included medication, physiotherapy, injection, and chiropractic. The monthly costs of the surgery cohort and nonsurgical cohort were presented at initial treatment, posttreatment 1, 3, 6, 9, and 12 months and yearly thereafter for 10 years.

Results: The characteristics and matching factors were well-balanced between the matched cohorts. Overall, surgery cohort spent $50.84/patient/month, while the nonsurgical cohort spent $29.34/patient/month (p<0.01). Initially, surgery treatment led to more charge to NHIS ($2,762) than nonsurgical treatment ($180.4) (p<0.01). Compared with the non-surgical cohort, the surgery cohort charged $33/month more for the first 3 months, charged less at 12 months, and charged approximately the same over the course of 10 years.

Conclusion: Surgical treatment initially led to more government reimbursement than nonsurgical treatment, but the charges during follow-up period were not different. The results of the present study should be interpreted in light of the costs of medical services, indirect costs, societal cost, quality of life and societal willingness to pay in each country. The monetary figures are implied to be actual economic costs but those in the reimbursement system instead reflect reimbursement charges from the government.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Analgesia / economics
  • Analgesia / statistics & numerical data
  • Cost of Illness*
  • Exercise Therapy / economics
  • Exercise Therapy / statistics & numerical data
  • Female
  • Humans
  • Intervertebral Disc Degeneration / economics*
  • Intervertebral Disc Degeneration / surgery
  • Intervertebral Disc Degeneration / therapy
  • Lumbosacral Region / pathology
  • Male
  • Manipulation, Chiropractic / economics
  • Manipulation, Chiropractic / statistics & numerical data
  • Middle Aged
  • Orthopedic Procedures / economics
  • Orthopedic Procedures / statistics & numerical data
  • Spinal Stenosis / economics*
  • Spinal Stenosis / surgery
  • Spinal Stenosis / therapy
  • Spondylolisthesis / economics*
  • Spondylolisthesis / surgery
  • Spondylolisthesis / therapy
  • Spondylolysis / economics*
  • Spondylolysis / surgery
  • Spondylolysis / therapy

Grants and funding

This work was financially supported by the New Faculty Startup Fund ($ 35,000) from Seoul National University (CHK), Seoul 03080, Republic of Korea. A grant ($1,300,000) from the Korea Health Technology Research & Development Project supported this study through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (HC15C1320) (CKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No authors in this study received salary or materials by funders.